J. E. Wraith

2.5k total citations
35 papers, 1.3k citations indexed

About

J. E. Wraith is a scholar working on Physiology, Rheumatology and Clinical Biochemistry. According to data from OpenAlex, J. E. Wraith has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 14 papers in Rheumatology and 12 papers in Clinical Biochemistry. Recurrent topics in J. E. Wraith's work include Lysosomal Storage Disorders Research (16 papers), Metabolism and Genetic Disorders (12 papers) and Glycogen Storage Diseases and Myoclonus (8 papers). J. E. Wraith is often cited by papers focused on Lysosomal Storage Disorders Research (16 papers), Metabolism and Genetic Disorders (12 papers) and Glycogen Storage Diseases and Myoclonus (8 papers). J. E. Wraith collaborates with scholars based in United Kingdom, United States and Switzerland. J. E. Wraith's co-authors include Maureen Cleary, J. H. Walter, F. White, J. P. R. Jenkins, David G. Hughes, Ashok Vellodi, Anupam Chakrapani, Kenneth L. Tyler, Brian Fowler and John H. Walter and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and The Journal of Pediatrics.

In The Last Decade

J. E. Wraith

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. E. Wraith United Kingdom 20 692 437 434 381 242 35 1.3k
Julian Raiman Canada 24 738 1.1× 334 0.8× 439 1.0× 559 1.5× 331 1.4× 58 1.5k
Agnieszka Jurecka Poland 21 649 0.9× 180 0.4× 293 0.7× 405 1.1× 446 1.8× 63 1.2k
Carolina Fischinger Moura de Souza Brazil 19 427 0.6× 362 0.8× 279 0.6× 507 1.3× 170 0.7× 110 1.2k
Serena Gasperini Italy 16 443 0.6× 185 0.4× 282 0.6× 223 0.6× 146 0.6× 64 880
C B Whitley United States 17 556 0.8× 122 0.3× 209 0.5× 287 0.8× 214 0.9× 30 970
Ana María Martins Brazil 21 1.2k 1.7× 113 0.3× 361 0.8× 251 0.7× 513 2.1× 101 1.4k
I Maire France 17 785 1.1× 82 0.2× 287 0.7× 341 0.9× 279 1.2× 85 1.2k
David Coman Australia 20 302 0.4× 302 0.7× 149 0.3× 583 1.5× 131 0.5× 79 1.2k
Nicole Muschol Germany 23 893 1.3× 84 0.2× 228 0.5× 291 0.8× 297 1.2× 93 1.3k
Ed Wraith United Kingdom 11 718 1.0× 82 0.2× 203 0.5× 149 0.4× 242 1.0× 24 910

Countries citing papers authored by J. E. Wraith

Since Specialization
Citations

This map shows the geographic impact of J. E. Wraith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. E. Wraith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. E. Wraith more than expected).

Fields of papers citing papers by J. E. Wraith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. E. Wraith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. E. Wraith. The network helps show where J. E. Wraith may publish in the future.

Co-authorship network of co-authors of J. E. Wraith

This figure shows the co-authorship network connecting the top 25 collaborators of J. E. Wraith. A scholar is included among the top collaborators of J. E. Wraith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. E. Wraith. J. E. Wraith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muenzer, Joseph, Michael Beck, Christine M. Eng, et al.. (2010). Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome. Genetics in Medicine. 13(2). 95–101. 173 indexed citations
2.
Wraith, J. E.. (2009). Enzyme replacement therapy for the management of the mucopolysaccharidoses. International Journal of Clinical Pharmacology and Therapeutics. 47 Suppl 1. S63–5. 19 indexed citations
3.
Cox‐Brinkman, Josanne, Jaap Jan Boelens, J. E. Wraith, et al.. (2006). Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome. Bone Marrow Transplantation. 38(1). 17–21. 82 indexed citations
4.
Wraith, J. E.. (2006). Limitations of enzyme replacement therapy: Current and future. Journal of Inherited Metabolic Disease. 29(2-3). 442–447. 70 indexed citations
5.
Dumas, Helene M., et al.. (2004). Physical performance testing in mucopolysaccharidosis I: a pilot study. Pediatric Rehabilitation. 7(2). 125–131. 21 indexed citations
6.
Suormala, Terttu, Matthias R. Baumgartner, David Coelho, et al.. (2004). The cblD Defect Causes Either Isolated or Combined Deficiency of Methylcobalamin and Adenosylcobalamin Synthesis. Journal of Biological Chemistry. 279(41). 42742–42749. 90 indexed citations
7.
Roland, N.J., et al.. (2003). Hearing loss due to mannosidosis and otitis media with effusion. A case report and review of audiological assessments in children with otitis media with effusion. The Journal of Laryngology & Otology. 117(4). 307–309. 6 indexed citations
8.
Johnson, Trevor N., Amin Rostami‐Hodjegan, Anupam Chakrapani, et al.. (2002). An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuria. British Journal of Clinical Pharmacology. 54(2). 140–146. 22 indexed citations
9.
Wraith, J. E.. (2001). Current topic: Ornithine carbamoyltransferase deficiency. Archives of Disease in Childhood. 84(1). 84–88. 35 indexed citations
10.
Chakrapani, Anupam, Maureen Cleary, & J. E. Wraith. (2001). Detection of inborn errors of metabolism in the newborn. Archives of Disease in Childhood Fetal & Neonatal. 84(3). F205–F210. 39 indexed citations
11.
Walter, J. H., J. E. Wraith, F. White, Craig A. Bridge, & J. E. Till. (1998). Strategies for the treatment of cystathionine β-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years. European Journal of Pediatrics. 157(S2). S71–S76. 69 indexed citations
12.
Hughes, David G., et al.. (1997). MRI of the brain and craniocervical junction in Morquio's disease. Neuroradiology. 39(5). 381–385. 53 indexed citations
14.
Hughes, David G., et al.. (1996). Magnetic resonance imaging of the brain, neck and cervical spine in mild hunter's syndrome (mucopolysaccharidoses type II). Clinical Radiology. 51(10). 719–723. 45 indexed citations
15.
Cleary, Maureen, et al.. (1995). Magnetic resonance imaging in phenylketonuria: Reversal of cerebral white matter change. The Journal of Pediatrics. 127(2). 251–255. 91 indexed citations
16.
Scott, Hamish S., Paul V. Nelson, Alan Cooper, et al.. (1992). Mucopolysaccharidosis type I (Hurler syndrome): Linkage disequilibrium indicates the presence of a major allele. Human Genetics. 88(6). 701–702. 15 indexed citations
17.
Cleary, Maureen & J. E. Wraith. (1991). Antenatal diagnosis of inborn errors of metabolism.. Archives of Disease in Childhood. 66(7 Spec No). 816–822. 2 indexed citations
18.
Cooper, Alan, Margaret J. Thornley, & J. E. Wraith. (1991). First‐trimester diagnosis of hunter syndrome: Very low iduronate sulphatase activity in chorionic villi from a heterozygous female fetus. Prenatal Diagnosis. 11(9). 731–735. 5 indexed citations
19.
O'Driscoll, J. B., M. H. Beck, M Lendon, J. E. Wraith, & I. B. Sardharwalla. (1990). Cutaneous presentation of sarcoidosis in an infant. Clinical and Experimental Dermatology. 15(1). 60–62. 3 indexed citations
20.
Wraith, J. E.. (1989). Diagnosis and management of inborn errors of metabolism.. Archives of Disease in Childhood. 64(10 Spec No). 1410–1415. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026